And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal to daydream about weekend plans. Our agenda, once again, is rather modest. We hope to spend time with a couple of our short people — busy as they are — take a nap or three, catch up on sundry tasks, and maybe do a little reading. And what about you? This may be an opportunity to see a moving picture show, visit someone special, or place bets on how much longer it may be before the U.S. government returns to normal, such as it is. Well, whatever you do, have a grand time. But be safe. Enjoy, and see you soon …
Massachusetts Gov. Charlie Baker is seeking legislative authority for MassHealth to negotiate prices directly with manufacturers of high-cost drugs that have little or no competition, CommonWealth writes. If the effort fails to produce savings, the state would put drug makers through a rate-setting process followed by regulatory and legal penalties if the company fails to charge the target price. State officials say 20 drugs recently launched or pending federal regulatory approval are expected to cost $100 million annually for the state’s Medicaid program, after expected rebates are deducted.
About the Author Reprints
